dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies.
about
New approaches for identifying and testing potential new anti-asthma agents.Modulation of the IL-23/IL-17 axis by fenofibrate ameliorates the ovalbumin/lipopolysaccharide-induced airway inflammation and bronchial asthma in rats.The prostaglandin D receptor 2 pathway in asthma: a key player in airway inflammation
P2860
dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
dIvergEnt: How IgE Axis Contri ...... Asthma and Anti-IgE Therapies.
@en
type
label
dIvergEnt: How IgE Axis Contri ...... Asthma and Anti-IgE Therapies.
@en
prefLabel
dIvergEnt: How IgE Axis Contri ...... Asthma and Anti-IgE Therapies.
@en
P2093
P2860
P921
P356
P1476
dIvergEnt: How IgE Axis Contri ...... Asthma and Anti-IgE Therapies
@en
P2093
Antonio Nieto
Christian Domingo
Luis Prieto
Luis Pérez de Llano
Marta Lleonart
Óscar Palomares
P2860
P356
10.3390/IJMS18061328
P407
P577
2017-06-21T00:00:00Z